Education
About Us
Working with TipRanks
Follow Us
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.14M | $ 20.97M | $ 41.87M | $ 23.03M | $ 135.08M |
| Gross Profit | $ 6.33M | $ 14.54M | $ 34.35M | $ 21.47M | $ 0.00 |
| Operating Income | $ -55.78M | $ -18.66M | $ -21.19M | $ -89.08M | $ 5.38M |
| EBITDA | $ -62.60M | $ -17.25M | $ -20.45M | $ -86.89M | $ 8.73M |
| Net Income | $ -70.87M | $ -17.35M | $ -20.54M | $ -88.44M | $ 8.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 37.90M | $ 22.92M | $ 43.74M | $ 167.03M | $ 180.93M |
| Total Assets | $ 43.83M | $ 27.00M | $ 45.10M | $ 247.06M | $ 271.16M |
| Total Debt | $ 44.45M | $ 368.00K | $ 450.00K | $ 3.67M | $ 5.28M |
| Net Debt | $ 6.54M | $ -22.55M | $ -21.04M | $ -9.78M | $ -26.41M |
| Total Liabilities | $ 48.42M | $ 89.06M | $ 90.15M | $ 19.53M | $ 22.16M |
| Stockholders' Equity | $ -4.59M | $ -62.06M | $ -45.05M | $ 227.52M | $ 249.00M |
| Cash Flow | |||||
| Free Cash Flow | $ -61.96M | $ -21.04M | $ -17.92M | $ -60.13M | $ -5.84M |
| Operating Cash Flow | $ -60.92M | $ -21.04M | $ -17.87M | $ -60.09M | $ -5.49M |
| Investing Cash Flow | $ 48.74M | $ 22.47M | $ -22.00M | $ -4.75M | $ -20.27M |
| Financing Cash Flow | $ -3.60M | $ 2.00K | $ 4.00K | $ 46.61M | $ 39.14M |
Tvardi Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.